lobbying_activities: 2869822

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2869822	c3fb785d-c448-45ae-97ff-37dba76b30dc	Q3	ACG ADVOCACY	2057	AMGEN USA INC.	2022	third_quarter	CPT	Patent policy.	SENATE	50000		0	0	2022-10-18T01:50:10-04:00